Showing 1 - 4 results of 4 for search 'Igho Ofotokun', query time: 0.10s Refine Results
  1. 1
    Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts

    Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts by Thierry Tiendrebeogo, Karen Malateste, Armel Poda, Albert Minga, Cecile D. Lahiri, Oliver Ezechi, Didier K. Ekouevi, Igho Ofotokun, Antoine Jaquet, the IeDEA West Africa Collaboration

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cytokine concentration and T cell subsets in the female genital tract in the presence of bacterial vaginosis and Trichomonas vaginalis

    Cytokine concentration and T cell subsets in the female genital tract in the presence of bacterial vaginosis and Trichomonas vaginalis by Marisa R. Young, Lisa B. Haddad, Lisa B. Haddad, Lyle McKinnon, Walter O. Ochieng, Marta Rowh, Amanda Gill, Igho Ofotokun, Supriya D. Mehta, Supriya D. Mehta

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Integration of Longitudinal Metabolome and Lipidome Changes Associated With Weight Gain in Women With HIV After Integrase Strand Transfer Inhibitor Initiation – A Pilot Study

    Integration of Longitudinal Metabolome and Lipidome Changes Associated With Weight Gain in Women With HIV After Integrase Strand Transfer Inhibitor Initiation – A Pilot Study by Chin An Yang, Sami Teeny, C Christina Mehta, Qian Yang, Tsungirirai Maramba, Igho Ofotokun, Anandi N Sheth, Kristal M Maner-Smith, Mohammed K Ali, Dean P Jones, Young-Mi Go, Thomas R Ziegler, Cecile D Lahiri, Jessica A Alvarez

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Disparities in dolutegravir utilisation in children, adolescents and young adults (0–24 years) living with HIV. An analysis of the IeDEA Pediatric West African cohort

    Disparities in dolutegravir utilisation in children, adolescents and young adults (0–24 years) living with HIV. An analysis of the IeDEA Pediatric West African cohort by Valériane Leroy, Anandi Sheth, Julie Jesson, Jean Jacques Koffi, Antoine Jaquet, François Dabis, Didier Koumavi Ekouevi, Karen Malateste, Olivia Keiser, Lehila Bagnan, Simon Boni, Madeleine Amorissani Folquet, Mariam Sylla, Olivier Marcy, Raoul Moh, Gildas Boris Hedible, Sophie Desmonde, Joycelyn Dame, Agatha David, Madeleine Amorissani-Folquet, Sylvie N'Gbeche, Elom Takassi, François Tanoh Eboua, Kouadio Kouakou, Lehila Bagnan Tossa, Caroline Yonaba, Jocelyn Dame, Sylvie Marie N’Gbeche, Fatoumata Dicko Traore, Oliver Ezchechi, Rosemary Audu, Charlotte Bernard, Caroline Couturier, Marie Kerbie Plaisy, Elodie Rabourdin, Thierry Tiendrebeogo, Désiré Dahourou, Emile Sodinyessi, Jean-Claude Azani, Kadidja Diarra, Maika Bengali, Abdoulaye Cissé, Guy Gnepa, Eric Komena, Séverin Lenaud, Eulalie Kangah, Igho Ofotokun, Cecile Delille Lahiri, Noëlle Benzekri, Geoffrey Gottlieb

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: